Virgilagicicin

Send Inquiry
Virgilagicicin
Details
•Product Name: Virgilagicin (Gram-positive active antibiotic)
•Molecular Formula: C₆₅H₁₀₆N₁₈O₁₉
•Molecular Weight: 1443.65 Da
•Purity (HPLC): ≥95%
Related Documents
•COA
•MS Report
•HPLC Purity Report
•Compound Solubility and Storage Guide
Category
Antimicrobial Peptides
Share to
Description

Shanghai Sonyt Biotechnology Co., Ltd. is one of the leading manufacturers and suppliers of virgilagicicin in China, also supports custom service. Welcome to wholesale bulk high quality virgilagicicin from our factory. Contact us for more details.

 

Description Virgilagicin is an antibiotic active against Gram-positive bacteria (InvivoChem V106124, molecular formula C65H106N18O19, molecular weight 1443.65 Da). Its unique mechanism lies in dual polyprenyl phosphate binding capability - it can simultaneously chelate two different essential polyprenyl phosphate lipid carriers, which function as transmembrane transporters of glycosyl and peptidyl units in bacterial cell wall peptidoglycan biosynthesis. By simultaneously blocking both carriers, Virgilagicin effectively inhibits cell wall synthesis, and due to the dual-target mechanism, bacteria are unlikely to develop resistance through single-site mutations. Widely used in anti-Gram-positive (including MRSA, VRE and other drug-resistant bacteria) drug development, cell wall biosynthesis mechanism research and anti-resistance antibiotic design.
Structure type Polyprenyl phosphate-binding antibiotic (dual target)
Solubility Soluble in DMSO, methanol
Storage Powder at -20C, dry, protected from light

 

Product Basic Information Table

 

Product Standard English Name Product Abbreviation / Alias Function Tags (comma-separated) Core Structure Molecular Formula Exact Mass (Da) Average MW (Da) Salt Form Length (aa)
Virgilagicicin Virgilagicicin; Virgibacillus-derived cyclic bacteriocin Antimicrobial peptide, Gram-positive targeting, bacteriocin, anti-resistant bacteria, biopreservation Cationic cyclic bacteriocin from Virgibacillus spp., forming a rigid conformation via intramolecular disulfide bond and hydrophobic interactions; specifically acts on Gram-positive bacterial cell membranes, potent against drug-resistant staphylococci and enterococci C₆₅H₉₇N₁₇O₁₂S₂ 1371.7 ~1372.8 Free peptide 14

 

Physicochemical Solubility & Storage Parameters

 

Product Code Appearance Long-term Storage Short-term Storage Solution Stability Solid Powder Stability
PEP-VIRGI White powder Store at -20°C, sealed, dry and protected from light. Aliquot for storage. Stable for 1 month at 2–8°C in sealed dry condition; stable for shipping at ambient temperature. Stable for 7 days at 4°C. Soluble in dilute acetic acid and acidic buffers. Cyclic structure is protease-resistant and stable over a broad pH range; slightly reduced activity at high salt. Stable for 2 years at -20°C, dry and protected from light.

Functional Description

 

Product Code Frontend Short Summary (for search list display) Detailed Biological Function Description Applicable Research Areas (comma-separated) Targets / Pathways
PEP-VIRGI Cyclic virgilagicicin targeting drug-resistant Gram-positive bacteria Virgilagicicin is a cationic cyclic bacteriocin from Virgibacillus, with a highly rigid conformation stabilized by intramolecular disulfide and hydrophobic interactions. It specifically binds phosphatidylglycerol in Gram-positive membranes, inserts and disrupts the bilayer, causing cytoplasmic leakage and cell death, with potent activity against MRSA, VRE and other MDR Gram-positive strains. MDR Gram-positive infections, bacteriocin research, cyclic peptide antibiotics, biopreservation, anti-MRSA drugs Gram-positive membrane phospholipids; membrane integrity disruption; intracellular ion homeostasis loss

 

 

 

 

Hot Tags: virgilagicicin, China virgilagicicin manufacturers, suppliers, factory, 143459-88-5, 188713-80-6, 79404-91-4, antimicrobial peptides, CAS 79404 91 4, Elf18

Send Inquiry